Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Dec 28, 2020 11:23am
109 Views
Post# 32187347

RE:RE:RE:RE:RE:RE:Watch VXLLF today !

RE:RE:RE:RE:RE:RE:Watch VXLLF today !If you think Moderna, Pfizer and Astrazeneca covid vaccines will work on the news strains of covid, think again because those three vaccines were made based on the initial genetic map back in January, now that genetic map has changed.

"The new variant of COVID-19 named “VUI 202012/01” includes a genetic mutation in the “spike” protein that could be the cause of immediate and easy spread of the virus amongst people. While the variant was first in the south-east of England, it has now triggered a sense of fear in all other parts of the world. The variant is said to have at least 17 mutations that can affect the shape of the virus, including the spike protein that gives the coronavirus family their name. While nothing further has been confirmed, scientists have suggested that this new strain could be the reason behind the faster spread of the virus."

VXL will be in spot light next year, Corvax offers a solution for the quick changing spike protein.



WalkingDead01 wrote:

 

birch1 wrote: Nice!

 

 

.19 with 400k volume... very nice !



<< Previous
Bullboard Posts
Next >>